TRANSFER LATEST! Arsenal launch stunning £41m move for Inter Milan star

admin fyvrlbbjjswv , , , , , , , , , , , , , ,

first_img1 Mauro Icardi in action for Inter Milan Arsenal have made a £41m bid for Inter Milan striker Mauro Icardi, according to reports in Italy.The Gunners are in the market for a new forward this summer and they have been linked with a number of players.Lyon striker Alexandre Lacazette is one reported target, while the club have also shown an interest in Napoli star Gonzalo Higuain.But, according to Corriere dello Sport, Arsenal have now turned their attentions to Icardi by making a £41m offer.The 23-year-old is reportedly ready to leave the San Siro this summer in search of Champions League football.Both Juventus and Napoli are already weighing up moves for him – but Arsenal are prepared to offer him wages of £96,000-a-week to tie up a deal.last_img

You May Also Like..

Covid-19 drug maker’s share price triples! Here’s what I’m doing now

first_img Enter Your Email Address Image source: Getty Images I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Manika Premsingh | Tuesday, 28th April, 2020 | More on: DDDD The share price of 4D pharma (LSE: DDDD) is on a tear as I write. It’s up a whole 197% from its lowest point in late March. This is a sharp rise by any standards. And for good reason.It received a go ahead for the next phase of its Covid-19 treatment a few days ago.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Long-term potentialPromising as this sounds, as a long-term investor I’d like to take a closer look at DDDD to understand its potential prospects. It was founded in 2014, and has been listed on AIM since. It’s pre-revenue right now and is researching a line of treatment called ‘live biotherapeutics’. This treatment focuses on gut bacteria to find cures for a range of diseases. I reckon it could be a while before these cures become successful revenue generators for 4D pharma.The challenging Covid-19 fightIt’s also entirely likely that some treatments may not be immediately successful, especially when it comes to Covid-19. Take for instance, the case of Remdesivir, a Covid-19 drug produced by US-based company Gilead Sciences, which hasn’t been effective in its first clinical trials. Or consider France’s Sanofi’s rheumatoid arthritis drug, which can be used in only the most affected Covid-19 patients. It was earlier believed to be a potential cure for a broader set of those infected according to a Reuters report. The key point here is that it could be a while before we’d see the fruits of 4D pharma’s labour show up in its financials. If I’m truly convinced of investing in companies that are in the trenches in the fight against coronavirus, I’d consider a different approach. I’d donate to medical research if the cause calls out to me. There’s much research underway to provide better treatments for critical illnesses. But that’s not investment, and shouldn’t be seen as such.My goal as an investor is to try my best to ensure returns. For this reason, I’m most inclined to invest in those companies that already have a proven track record.Considering FTSE 100 alternativesFTSE 100 pharma biggies are my bet for the long-term as a result. Consider the example of GlaxoSmithkline,  which has also recently been in the news for working on a coronavirus vaccine. This incidentally, is also a collaboration with Sanofi, which, as I pointed out earlier is already providing treatment in critical Covid-19 cases. It’s expected to be available only in the second half of 2021. Or AstraZeneca, which is working on a coronavirus treatment as well. Of course, it will be some time before we know the results of these endeavours. But these are already established companies. They are well-diversified and are financially sound. Moreover, they are likely to come out quite unscathed by the coronavirus crisis, and indeed the stock market crash. I think they are better investments for now.  Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! See all posts by Manika Premsingh Covid-19 drug maker’s share price triples! Here’s what I’m doing nowcenter_img Our 6 ‘Best Buys Now’ Shares Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Simply click below to discover how you can take advantage of this. Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. “This Stock Could Be Like Buying Amazon in 1997”last_img

Episcopal Church Office of Government Relations releases new resource to…

first_img Ya no son extranjeros: Un diálogo acerca de inmigración Una conversación de Zoom June 22 @ 7 p.m. ET Episcopal Charities of the Diocese of New York Hires Reverend Kevin W. VanHook, II as Executive Director Episcopal Charities of the Diocese of New York Rector/Priest in Charge (PT) Lisbon, ME Episcopal Migration Ministries’ Virtual Prayer Vigil for World Refugee Day Facebook Live Prayer Vigil June 20 @ 7 p.m. ET Rector Albany, NY Assistant/Associate Rector Morristown, NJ Missioner for Disaster Resilience Sacramento, CA Health & Healthcare Featured Events Priest-in-Charge Lebanon, OH Inaugural Diocesan Feast Day Celebrating Juneteenth San Francisco, CA (and livestream) June 19 @ 2 p.m. PT In response to the increased prevalence of disinformation campaigns, The Episcopal Church’s Office of Government Relations has released the resource “Misinformation, Disinformation, Fake News: Why Do We Care?”While misinformation has been used for centuries, it has become especially prevalent and difficult to identify with the rise of social media platforms and the general expansion of internet access. Misinformation often spreads faster and is seen by a broader audience than legitimate news. This means that when misinformation is spread about a topic like the coronavirus disease or the U.S. 2020 Census, it can pose a serious threat to public health and social systems as individuals are more likely to be exposed to misinformation than expert advice.“This resource is designed not only to educate our audience about misinformation but also to offer concrete steps for individuals and organizations on how to identify and limit its spread,” explains Rebecca Linder Blachly, director, The Episcopal Church Office of Government Relations. “While misinformation is often relatively harmless, there are targeted disinformation campaigns designed to cause harm and to shut down important conversations about significant issues our society faces. We want our audience to have the knowledge and resources to recognize and respond to these damaging campaigns.”In addition to concrete tips on how to identify and limit the spread of misinformation, this resource offers an overview of the misinformation landscape, the structure of disinformation campaigns, and the use of misinformation in elections.Support for this resource, as well as continued advocacy for policy and appropriate safeguards to reduce content that is false and designed to cause harm (also known as disinformation) are key elements of Resolution MB 016 Misinformation and Elections passed by the Executive Council of The Episcopal Church at their February 2020 meeting.Learn more about the Office of Government Relations and their work here.To sign up for the Episcopal Public Policy Network, click here. Youth Minister Lorton, VA Cathedral Dean Boise, ID Rector Smithfield, NC Rector Martinsville, VA Associate Priest for Pastoral Care New York, NY New Berrigan Book With Episcopal Roots Cascade Books Rector Knoxville, TN Virtual Celebration of the Jerusalem Princess Basma Center Zoom Conversation June 19 @ 12 p.m. ET The Church Investment Group Commends the Taskforce on the Theology of Money on its report, The Theology of Money and Investing as Doing Theology Church Investment Group Submit an Event Listing Rector and Chaplain Eugene, OR Press Release Service Rector Collierville, TN Rector Bath, NC Family Ministry Coordinator Baton Rouge, LA Rector (FT or PT) Indian River, MI Bishop Diocesan Springfield, IL The Church Pension Fund Invests $20 Million in Impact Investment Fund Designed to Preserve Workforce Housing Communities Nationwide Church Pension Group Episcopal Church Office of Government Relations releases new resource to help identify misinformation Rector Shreveport, LA This Summer’s Anti-Racism Training Online Course (Diocese of New Jersey) June 18-July 16 Canon for Family Ministry Jackson, MS Remember Holy Land Christians on Jerusalem Sunday, June 20 American Friends of the Episcopal Diocese of Jerusalem Associate Rector for Family Ministries Anchorage, AK TryTank Experimental Lab and York St. John University of England Launch Survey to Study the Impact of Covid-19 on the Episcopal Church TryTank Experimental Lab Submit a Job Listing Rector Washington, DC Tags Episcopal Church Office of Public AffairsPosted Apr 2, 2020 Assistant/Associate Rector Washington, DC Curate (Associate & Priest-in-Charge) Traverse City, MI Featured Jobs & Calls In-person Retreat: Thanksgiving Trinity Retreat Center (West Cornwall, CT) Nov. 24-28 Rector Hopkinsville, KY Curate Diocese of Nebraska Director of Administration & Finance Atlanta, GA Course Director Jerusalem, Israel Seminary of the Southwest announces appointment of two new full time faculty members Seminary of the Southwest COVID-19, Rector Pittsburgh, PA Assistant/Associate Priest Scottsdale, AZ Rector Tampa, FL Director of Music Morristown, NJ Priest Associate or Director of Adult Ministries Greenville, SC AddThis Sharing ButtonsShare to PrintFriendlyPrintFriendlyShare to FacebookFacebookShare to TwitterTwitterShare to EmailEmailShare to MoreAddThis An Evening with Presiding Bishop Curry and Iconographer Kelly Latimore Episcopal Migration Ministries via Zoom June 23 @ 6 p.m. ET Join the Episcopal Diocese of Texas in Celebrating the Pauli Murray Feast Online Worship Service June 27 Submit a Press Release Back to Press Releases Rector Belleville, IL Associate Rector Columbus, GAlast_img

Fulgence Ouedraogo dropped badly in the lineout

first_imgTuesday Feb 19, 2008 Fulgence Ouedraogo dropped badly in the lineout On the weekend I watched the Top 14 meeting between Montpellier and Biarritz Olympique. The game was a hard fought and tight encounter, but just before the end young flanker Fulgence Ouedraogo suffered a bizarre injury in the lineout. Ouedraogo is Burkina Faso born and another in the line of African born flankers that turn out for France. He made his debut for his country, France, on the New Zealand tour of last year. He is a strong ball carrier and excellent at the breakdown. He’ll no doubt be a star performer for France in the future and is most definitely going to feature strongly in this years Six Nations. His Montpellier team mates didn’t do him any favours though when he got tossed up really high in the lineout, but then not brought back down to ground safely. This is a lesson in how NOT to support your lineout jumpers. Ouch.ADVERTISEMENT Posted By: rugbydump Share Send Thanks Sorry there has been an error See it to Believe it Related Articles 25 WEEKS AGO WATCH: Experts explain what actually happens… 26 WEEKS AGO WATCH: Leigh Halfpenny makes yet another… 26 WEEKS AGO Parisse alley-oop magic sets up brilliant… From the WebThis Video Will Soon Be Banned. Watch Before It’s DeletedSecrets RevealedYou Won’t Believe What the World’s Most Beautiful Girl Looks Like TodayNueeyWrinkle Remedy Stuns TV Judges: Forget Surgery, Do This Once DailySmart Life Reports90% of People Have No Idea What These Two Little Holes Are ForNueey10 Types of Women You Should Never MarryNueeyMen, You Don’t Need the Blue Pill If You Do This (Try Tonight)Smart Life ReportsThe content you see here is paid for by the advertiser or content provider whose link you click on, and is recommended to you by Revcontent. As the leading platform for native advertising and content recommendation, Revcontent uses interest based targeting to select content that we think will be of particular interest to you. We encourage you to view your opt out options in Revcontent’s Privacy PolicyWant your content to appear on sites like this?Increase Your Engagement Now!Want to report this publisher’s content as misinformation?Submit a ReportGot it, thanks!Remove Content Link?Please choose a reason below:Fake NewsMisleadingNot InterestedOffensiveRepetitiveSubmitCancellast_img

Leave a Reply

Your email address will not be published. Required fields are marked *